Lorin Van Nuland

Director at Cambrian BioPharma

Capital raised by Cambrian BioPharma

$123.8M+$123.8M latest round

1 Form D filing · first filed Jun 2026 · New York, NY

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

Cambrian BioPharmaBiotech · New York, NYsince Jun 2026

Director

Listed on Cambrian BioPharma's Form D filings

Company filings

via EDGAR · Form D for Cambrian BioPharma1

DateCompanyFormAmountRole on filing

Jun 30, 2026Cambrian BioPharmaForm D+$123.8M—

Form DJun 30, 2026 · Cambrian BioPharma+$123.8Mnot a signer

Overview

Last filing Jun 30, 2026

Lorin Van Nuland is on file as Director at Cambrian BioPharma in New York, NY. Cambrian BioPharma has 1 Form D filing on record, $123.8M raised in total.

Teammates

Cambrian BioPharma · 1

William DeVaulChief Legal OfficerSigner

Products

Cambrian BioPharma · 1

ATX-304Clinical-stage therapeutic

A pan-AMPK activator in clinical development (via pipeline company Amplifier Therapeutics) targeting age-related metabolic decline, with positive Phase 1b results in obesity and prediabetes.